Capital Research Global Investors 13D/13G Filings for Amgen Inc. (AMGN)

Capital Research Global Investors 13D and 13G filings for Amgen Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-11
12:22 pm
Sale
2022-02-14 13G Amgen Inc.
AMGN
Capital Research Global Investors 22,157,906
3.900%
-9,604,421decrease
(-30.24%)
Filing
2021-02-16
3:46 pm
Sale
2021-02-16 13G Amgen Inc.
AMGN
Capital Research Global Investors 31,762,327
5.500%
-3,575,312decrease
(-10.12%)
Filing